<html><head><meta content="text/html; charset=UTF-8" http-equiv="content-type"><style type="text/css">ol{margin:0;padding:0}table td,table th{padding:0}.c4{padding-top:0pt;padding-left:0pt;padding-bottom:0pt;line-height:2.0;border-left-width:0pt;margin-left:36pt;text-indent:-36pt;border-left-style:solid;orphans:2;widows:2;text-align:left}.c3{color:#000000;font-weight:400;text-decoration:none;vertical-align:baseline;font-size:11pt;font-family:"Arial";font-style:normal}.c1{padding-top:0pt;padding-bottom:0pt;line-height:1.15;orphans:2;widows:2;text-align:left;height:11pt}.c0{color:#000000;font-weight:400;text-decoration:none;vertical-align:baseline;font-size:12pt;font-family:"Times New Roman";font-style:normal}.c2{padding-top:0pt;padding-bottom:0pt;line-height:1.15;orphans:2;widows:2;text-align:left}.c8{padding-top:0pt;padding-bottom:0pt;line-height:2.0;orphans:2;widows:2;text-align:center}.c5{font-size:12pt;font-family:"Times New Roman";font-style:italic;font-weight:400}.c6{font-size:12pt;font-family:"Times New Roman";font-weight:400}.c9{background-color:#ffffff;max-width:468pt;padding:72pt 72pt 72pt 72pt}.c7{font-size:16pt;font-weight:700}.title{padding-top:0pt;color:#000000;font-size:26pt;padding-bottom:3pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}.subtitle{padding-top:0pt;color:#666666;font-size:15pt;padding-bottom:16pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}li{color:#000000;font-size:11pt;font-family:"Arial"}p{margin:0;color:#000000;font-size:11pt;font-family:"Arial"}h1{padding-top:20pt;color:#000000;font-size:20pt;padding-bottom:6pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}h2{padding-top:18pt;color:#000000;font-size:16pt;padding-bottom:6pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}h3{padding-top:16pt;color:#434343;font-size:14pt;padding-bottom:4pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}h4{padding-top:14pt;color:#666666;font-size:12pt;padding-bottom:4pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}h5{padding-top:12pt;color:#666666;font-size:11pt;padding-bottom:4pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}h6{padding-top:12pt;color:#666666;font-size:11pt;padding-bottom:4pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;font-style:italic;orphans:2;widows:2;text-align:left}</style></head><body class="c9 doc-content"><p class="c2"><span class="c7">Automation and Robotics in High-Throughput Screening: Accelerating Drug Discovery and Biomarker Identification</span><span class="c3"><br></span></p><p class="c2"><span class="c3">Automation and robotics have revolutionized various sectors, and the field of biomedical research is no exception. Particularly, high-throughput screening (HTS) of compounds or genetic samples, a crucial step in drug discovery and biomarker identification, has been significantly enhanced due to the integration of automation and robotics.</span></p><p class="c1"><span class="c3"></span></p><p class="c2"><span class="c3">High-Throughput Screening (HTS)</span></p><p class="c2"><span class="c3">High-throughput screening (HTS) is a method used in drug discovery and other life science fields to perform biological or chemical tests at scale. It involves the testing of hundreds of thousands of samples in parallel, often using automated liquid handling devices, multi-mode readers, and other devices paired with data processing and control software highresbio.com. HTS is a valuable tool in assessing pharmacological targets and profiling pharmacological agonists or antagonists for a given drug.</span></p><p class="c1"><span class="c3"></span></p><p class="c2"><span class="c3">Automation in HTS</span></p><p class="c2"><span class="c3">Automation in HTS involves the use of computer systems, various operating systems, a central robot, and complex scheduling software. The central robot is equipped with a gripper that can pick and place microplates around a platform. This process enables efficient and rapid screening of compounds or genetic samples, significantly accelerating the discovery of potential drugs or biomarkers.</span></p><p class="c1"><span class="c3"></span></p><p class="c2"><span class="c3">Role of Robotics in HTS</span></p><p class="c2"><span class="c3">Robotic automation technologies offer benefits of greater efficiency and higher quality, even for small volumes. Advanced hazardous drug compounding robots, for example, utilize a multi-station compounding approach to minimize motion and preparation time, thereby increasing workflow and output.</span></p><p class="c1"><span class="c3"></span></p><p class="c2"><span class="c3">Benefits of Automating the HTS Process</span></p><p class="c2"><span class="c3">Automating the HTS process can deliver significant acceleration and efficiency improvements. Utilizing dedicated robots to move labware between devices, controlled by dynamic scheduling software, enables many parallel operations to be performed in synchronization, greatly increasing throughput while maintaining controlled experimental conditions.</span></p><p class="c1"><span class="c3"></span></p><p class="c2"><span class="c3">Conclusion</span></p><p class="c2"><span class="c3">In conclusion, automation and robotics have the potential to revolutionize the field of high-throughput screening (HTS), leading to faster and more efficient discovery of potential drugs and biomarkers. As technology continues to evolve, it is expected that these tools will become even more integral to the process of drug discovery, offering new opportunities for advancements in the field.</span></p><p class="c1"><span class="c3"></span></p><p class="c8"><span class="c0">Works Cited</span></p><p class="c4"><span class="c6">&ldquo;High Throughput Screening Automation.&rdquo; </span><span class="c5">HighRes Biosolutions</span><span class="c0">, highresbio.com/applications/high-throughput-screening-automation/. Accessed 16 July 2023.</span></p><p class="c4"><span class="c6">Kriheli, Marino, et al. &ldquo;Robotic Automation Is the next Step for Hazardous Drug Compounding Practice.&rdquo; </span><span class="c5">Automate</span><span class="c0">, www.automate.org/blogs/robotic-automation-is-the-next-step-for-hazardous-drug-compounding-practice.</span></p><p class="c4"><span class="c6">Szyma&#324;ski, Pawe&#322;, et al. &ldquo;Adaptation of High-Throughput Screening in Drug Discovery&mdash;Toxicological Screening Tests.&rdquo; </span><span class="c5">International Journal of Molecular Sciences</span><span class="c0">, vol. 13, no. 1, 29 Dec. 2011, pp. 427&ndash;452, www.ncbi.nlm.nih.gov/pmc/articles/PMC3269696/, https://doi.org/10.3390/ijms13010427.</span></p><p class="c1"><span class="c3"></span></p><p class="c1"><span class="c3"></span></p></body></html>